Lumera, Harvard Proteomics Institute Will Use NAPPA Tech to Probe 200 Kinase Proteins | GenomeWeb
NEW YORK (GenomeWeb News) — Results of an ongoing collaboration between Lumera and the Harvard Institute of Proteomics have enabled the partners to try to use Lumera’s ProteomicProcessor biosensor to develop new diagnostics.
Since January, Harvard has served as a beta site for Lumera's platform. Researchers there have been trying to enable the ProteomicProcessor to analyze data from, their nucleic acid programmable protein array technology, also known as NAPPA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.